PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointment of Dr. Howard Mayer as Executive Vice President and Head of Research and Development, effective December 1st, 2019. He succeeds Dr. Alexandre Lebeaut, Executive Vice President, Research and Development, Chief Scientific Officer, who will retire from the company at the end of the year. Based in Cambridge, Mass, U.S., Dr. Mayer will report directly to David Meek, CEO, Ipsen and serve on the Executive Leadership Team. David Meek, CEO, Ipsen, commented, “As Ipsen enters its next phase of growth, it is my great pleasure to appoint Dr. Mayer to



This content is restricted to site members. If you are an existing user, please log in. New users may register too.